FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used to stimulate cognitive function in a healthy individual. Disclosed is a method for stimulating cognitive function in a healthy individual, comprising administering to individual from 2 to 100 mg per day of methylthioninium (MT), optionally divided into 2 or more doses, where MT is administered in the form of a LMTX compound of the following formula , where each of HnA and HnB (when present) are protic acids, which may be the same or may be different, and where p = 1 or 2; q = 0 or 1; n = 1 or 2; (p + q) × n = 2 or a hydrate or solvate thereof; and wherein the LMTX compound stimulates basal levels of acetylcholine and synaptophysin in an individual.
EFFECT: invention provides activation of neuron function in healthy subjects by stimulating basal levels of choline and synaptophysin.
27 cl, 1 dwg, 2 tbl, 3 ex
Title |
Year |
Author |
Number |
3β-(Benzyloxy)-17α-METHYL-PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS |
2019 |
- Piazza, Pier-Vincenzo
- Fabre, Sandy
- Monlezun, Stephanie
- Metna, Mathilde
- Vallee, Monique
- Revest, Jean-Michel
- Cota, Daniela
- Marsicano, Giovanni
- Marighetto, Aline
- Ozaita, Andres
- Maldonado, Rafael
|
RU2796005C2 |
USE OF A BENZOPYRAN DERIVATIVE FOR THE TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE ASSOCIATED WITH CALCIUM DYSREGULATION |
2023 |
- Zernov Nikita
- Melenteva Daria Maksimovna
- Bolshakova Anastasiia Viktorovna
- Popugaeva Elena Aleksandrovna
|
RU2804398C1 |
MEMANTINE THERAPY FOR ALZHEIMER'S DISEASE OF LOW AND LOW TO MODERATE SEVERITY |
2005 |
- Makdonal'D Skott
- Gergel Ajvan
- Shteffler Al'Brekht
- Mebius Khans-Jorg
- Virt Ivonne
- Potkin Stiven
|
RU2371173C2 |
DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS |
2005 |
|
RU2394570C2 |
HUMANIZED IMMUNE BODIES IDENTIFYING ALPHA-SINUCLEIN |
2012 |
- Saldankha Khose
- Nijdzhar Tarlochan S.
|
RU2575629C2 |
REDUCED SYSTEMIC LEVELS OR ACTIVITY OF REGULATORY T-CELLS FOR TREATING DISEASE AND CENTRAL NERVOUS SYSTEM INVOLVEMENT |
2017 |
- Eisenbach-Schwartz Michal
- Baruch Kuti
- Rosenzweig Neta
|
RU2815892C1 |
TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS |
2007 |
- Sid Brajan
- Mekehnik Dzhordan
|
RU2477634C2 |
HAEE PEPTIDE MAGNESIUM COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
2022 |
- Kozin Sergej Aleksandrovich
|
RU2784746C1 |
HAEE PEPTIDE ZINC COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
2022 |
- Kozin Sergej Aleksandrovich
|
RU2784319C1 |
HAEE PEPTIDE COPPER COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
2022 |
- Kozin Sergej Aleksandrovich
|
RU2784732C1 |